A Drop of Blood That Could Save Millions: The Future of Preeclampsia Diagnosis

A Drop of Blood That Could Save Millions: The Future of Preeclampsia Diagnosis

Author: by FemmeHealth Alliance August 7, 2025 Duration: 26:06

In this episode, healthcare investor and strategist Maryann Umoren Selfe is joined by Matthias Wipf, CEO of Swiss medtech company MOMM Diagnostics, to examine the systemic gaps in how we identify and fund life-saving healthcare infrastructure for women.

🟣 Why preeclampsia remains one of the most dangerous, misunderstood pregnancy complications

🟣 What point-of-care diagnostics like Pre-Exclude are doing differently

🟣 Why diagnostics in women’s health are underfunded and what that reveals about investor psychology

🟣 How preeclampsia connects to long-term cardiovascular risk 🟣 What’s holding back innovation in maternal health and how to change it

🟣 Why investing in maternal health benefits not just women, but entire health systems

Join 10,000+ readers of the FemmeHealth newsletter on Substack.

------------------

About MOMM Diagnostics:Founded in 2018, MOMM Diagnostics is reimagining maternal care with préXclude, a breakthrough test for early detection of preeclampsia. With just a drop of blood and a few minutes, their technology gives clinicians the power to act before pregnancy complications become emergencies. Born out of research collaborations in Switzerland and California, MOMM is part of a new wave of founders who are turning overlooked health problems into high-impact innovation. Learn more here.



Get full access to The Billion Dollar Blindspot at blog.billiondollarblindspot.com/subscribe

There's a vast, often overlooked frontier in business and innovation, and Blindspot Capital is mapping its terrain. This podcast digs into the ideas, trends, and tangible investment potential shaping the future of women's health, a sector that has historically been underfunded and underserved. Each episode moves beyond surface-level discussions to examine the systemic gaps and the consequential opportunities they create. You'll hear from founders, investors, researchers, and thinkers who are actively building and funding solutions in this space, sharing their on-the-ground experiences and hard-won insights. The conversations are grounded in the reality of entrepreneurship and market dynamics, exploring not just the "why" but the "how"-how new technologies are being applied, how businesses are scaling, and how capital can be deployed to generate both impact and returns. Tune in for a clear-eyed look at an area ripe for transformation, where understanding the blind spot isn't just about awareness, but about seeing a path forward for savvy builders and backers alike. This isn't a niche side conversation; it's a central dialogue about the next wave of growth in healthcare and technology, delivered through a podcast dedicated to substantive, forward-thinking analysis.
Author: Language: English Episodes: 18

Blindspot Capital
Podcast Episodes
The Menopause Information Crisis [not-audio_url] [/not-audio_url]

Duration: 31:16
Some markets follow a familiar script: a need emerges, founders respond, capital flows, and eventually, the sector matures. But women’s health doesn’t work like that.In a recent episode of Blindspot Capital, I sat down w…
Building FemTech Infrastructure in Asia [not-audio_url] [/not-audio_url]

Duration: 39:33
Some markets follow this script: A need appears. Entrepreneurs respond. Capital flows in. Eventually, the sector matures and innovation accelerates. But some markets don’t follow that script.In a recent episode of Blinds…
Why It Takes Years to Build in Women’s Health [not-audio_url] [/not-audio_url]

Duration: 34:44
Most innovation stories are told as clean upward lines. A founder has an idea. Investors come in. The product launches. Growth follows. Eventually there is an acquisition or an IPO, and the story looks inevitable in hind…
Why Women’s Heart Disease Is Still Misdiagnosed [not-audio_url] [/not-audio_url]

Duration: 34:58
In this episode of Blindspot Capital, Maryann sits down with Professor Angela Maas (cardiologist and pioneer of sex- and gender-specific cardiology) to unpack why women’s heart disease is still misunderstood and what med…
Tough Love for Women’s Health Founders [not-audio_url] [/not-audio_url]

Duration: 26:51
In this episode of Blindspot Capital, Maryann sits down with Lisa Suennen - longtime healthcare investor, founder of the Venture Valkyrie blog, and Managing Partner of the Go Red for Women Venture Fund to unpack one of t…
The Silent Ban: How Social Media Is Censoring Women’s Health [not-audio_url] [/not-audio_url]

Duration: 25:58
In this episode of Blindspot Capital, Maryann sits down with Anna O’Sullivan, co-founder of censhership.co.uk and FutureFemHealth, to unpack a deeply underrecognized systemic bias: the routine censorship of women’s healt…
Why Most Digital Health Startups Will Fail [not-audio_url] [/not-audio_url]

Duration: 30:18
Half the headlines in healthcare are hype. But what if we stopped chasing the next shiny thing and started fixing the fundamentals?In this episode of Blindspot Capital, I sit down with Sergei Polevikov, mathematician, in…